Detection of HIV-RNA-positive monocytes in peripheral blood of HIV- positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype

Cytometry

Volumn 31, Issue 4, 1998, Pages 265-274

  Patterson, Bruce K ^a   Mosiman, Victoria L ^a   Cantarero, Luis ^b   Furtado, Manohar ^a   Bhattacharya, Mondira ^c   Goolsby, Charles ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Aprogenex Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HIV; Immunophenotyping; In situ hybridization; In situ PCR; Monocytes; RNA

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; SAQUINAVIR; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; IMMUNOPHENOTYPING; MONOCYTE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD;

CELL LINE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KINETICS; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIREMIA;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031956807     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980401)31:4<265::AID-CYTO6>3.0.CO;2-I     Document Type: Article

References (49)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: A RANTES, MIP-1, MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958, 1996.
2. Andreoni M, Sarmati L, Ercoli L, Nicastri E, Giannini G, Galluzzo C, Pirillo MF, Vella S: Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS Res Hum Retroviruses 13:555-561. 1997.
3. Bagnarelli P, Valenza A, Menzo S, Manzin A, Scalise G, Varaldo PE, Clementi M: Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 68:2495-2502, 1994.
4. Bayer JA, Bauman JGJ: Flow cytometric detection of beta-globin mRNA in murine haemopoietic tissues using flourescent in situ hybridization. Cytometry 11:132-143, 1990.
5. Blauvelt A, Clerici M, Lucey DR, Steinberg SM, Yarchoan R, Walker R, Shearer GM, Katz SI: Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons, J Immunol 154:3506-3515, 1995.
6. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR (#RR-17) 41:1-19, 1992.
7. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 185:621-628, 1997.
8. Cornelissen M, Mulder-Kampigna G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hock L, Sol C, Coutinho R, Goudsmit J: Syncytium-inducing SI phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 69:1810-18, 1995.
9. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenncr-Racz K, Haasc AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 363:359-361, 1993.
10. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877, 1996.
11. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS: Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 86:2365-2368, 1989.
12. Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, Fauci AS, Siebenlist UK: A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J Exp Med 180:1445-1456, 1994.
13. + T-cell number decline in human immunodeficiency virus type 1-infected individuals. J Virol 69:2092-2100, 1995.
14. Gendelman H, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lana HC, Fauci AS, Burke DS, Skillman D, Meltzer MS: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167:1428-1441, 1988.
15. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM: The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyinositol linkage. J Immunol 141:547-552, 1988.
16. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126, 1995.
17. Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin JM: HIV-1 in blood monocytes: Frequency of proviral DNA using PCR and comparison with total CD4 count. AIDS Res Hum Retroviruses 8:261-268, 1992.
18. Lalli E, Gibellini D, Santi S, Facchini A: In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Anal Biochem 207:298-303, 1992.
19. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183-289, 1993.
20. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH: Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes. J Virol 65:3973-3985, 1991.
21. McElrath MJ, Steinman RM, Cohn ZA: Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J Clin Invest 87:27-30, 1991.
22. Mosiman VL, Patterson BK, Canterero L, Goolsby CL: Reducing cellular autofluorescence in flow cytometry: An in situ method. Cytometry 30:151-156, 1997.
23. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170, 1996.
24. Meltzer MS, Gendelman HE: Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Topics Microsc Immunol 181:239-261, 1992.
25. Panteleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 363:355-358, 1993.
26. Patterson BK: PCR in situ hybridization: Applications and modifications. In: PCR In Situ Hybridization, Principles and Practice, O'Leary JJ, Herrington CS (eds). Oxford University Press, New York, 1998.
27. + cells harboring human immunodeficiency virus type 1 (HIV-1) DNA by dual immunophenotyping and PCR-driven in situ hybridization: Evidence of epitope masking of the CD4 cell surface molecule in vivo. J Virol 69:4316-4322, 1995.
28. Patterson BK, Jiyamapa D, Mayrand PE, Hoff B, Abramson R, Garcia P: Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 5′-nuclease assay (FISNA). Nucleic Acids Res 24:3656-3658, 1996.
29. Patterson BK, Till M, Otto P, Goolsby C, Furtado M, McBride L, Wolinsky SM: Detection of HIV-1 DNA and mRNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260:976-979, 1993.
30. Peng H, Reinhart TA, Retzel EF, Staskus KA, Zupancic M, Haase AT: Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology 206:16-27, 1994.
31. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586, 1996.
32. Phillips AN: Reduction of HIV concentration during acute infection: Independence from a specific immune response. Science 271:497-499, 1996.
33. Pomerantz RJ, Trono D, Feinberg MB, Baltimore D: Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 61:1271-1276, 1990.
34. Ravichandran KS, Semproni AR, Goldsby RA, Osborne BA: Immunoglobulin VH usage analysis by fluorescent in situ hybridization and flow cytometry. J Immunol Methods 153:249-259, 1992.
35. Re MC, Furlini G, Gibellini D, Vignoli M, Ramazzotti E, Lolli S, Ranieri S, La Placa M: Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometric analysis of the product of an in situ PCR assay. J Clin Microsc 32:2152-2157, 1994.
36. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA: Increased susceptability of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 89:176-183, 1992.
37. + T-cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 113:438-443, 1990.
38. Schnittman SM, Psallidopoulous MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman MP, Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T-cell that maintains expression of CD4. Science 245:305-308, 1989.
39. Schuitemaker H, Koostra N, deGoede R, de Wolf R, Miedema F, Tersmette M: Monocytotropic human immunodeficiency virus type1 (HIV-I) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 65:356-363, 1991.
40. Spear GT, Ou C-Y, Kessler HA, Moore JL, Schochetman G, Landay AL: Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV-1)-infected persons for HIV DNA. J Infect Dis 162:1239-1244, 1990.
41. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of Simian immunodeficiency virus into rhesus macaques. J Exp Med 183:215-225, 1996.
42. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA: HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J 9:1551-1560, 1990.
43. + T cells are infectable by human immunodeficiency virus but do not release virus after activation. J Virol 69:5659-5665, 1995.
44. Taylor JMG, Fahey JL, Detels R, Giorgi JV: CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J Acq Imm Def Syn 2:114-124, 1989.
45. high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25:3418-3424, 1995.
46. Turner BJ, Hecht FM, Ismail RB: CD4+ T-lymphocyte measures in the treatment of individuals infected with human immunodeficiency virus type 1: A review for clinical practitioners. Arch Intern Med 154:1561-1573, 1994.
47. Wei X, Ghosh SK, Taylor M, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffcr S, Nowak MA, Hahn BH, Saag MS, Shaw GS: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122, 1995.
48. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1434, 1990.
49. Zerlauth G, Maier E, Chehadeh H, Zimmerman K, Eibl MM, Mannhalter JW: Interaction with human immunodeficiency virus type 1 modulates innate effector functions of human monocytes. J Infect Dis 172:1598-1601, 1995.